Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation

Leukemia

Volumn 16, Issue 1, 2002, Pages 13-21

  Schaap, N ^a   Schattenberg, A ^a   Mensink, E ^a   Preijers, F ^a   Hillegers, M ^a   Knops, R ^a   Pennings, A ^a   Boezeman, J ^a   Geurts van Kessel, A ^a   de Pauw, B ^a   de Witte, T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anthracyclines; Long term mixed chimerism; Red blood cell phenotyping; Short tandem repeats; T cell depleted allogeneic stem cell transplantation

Indexed keywords

ANTHRACYCLINONE DERIVATIVE; CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IDARUBICIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGRAFT; APLASTIC ANEMIA; ARTICLE; B LYMPHOCYTE; CANCER RECURRENCE; CANCER SURVIVAL; CELL TYPE; CHIMERA; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOGENETICS; DISEASE SEVERITY; DONOR; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MONITORING; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; SIBLING; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CELL SURVIVAL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MYELOID CELLS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 85009893939     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402343     Document Type: Article

References (56)

1. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation
2. Application of a polymorphic Y microsatellite to the detection of post bone marrow transplantation chimaerism
3. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation
4. Outcome of transplantation for standard risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen
5. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow
6. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: Is T cell dose important in determining biological response?
7. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency
8. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia
9. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: A stable equilibrium
10. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction
11. +-selected peripheral blood cells
12. Determinants of engraftment after allogeneic marrow transplantation
13. In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMT
14. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation
15. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies
16. Detection of minimal residual disease and persistence of host-type hematopoiesis: A study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for myelogenous leukemia
17. Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation
18. Mixed chimerism after sex-mismatched allogeneic BMT: Evaluation of two molecular techniques
19. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation
20. Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation
21. A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials
22. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
23. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
24. Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse
25. Comparison of chimerism of red cells with that of granulocytes, T lymphocytes, and bone marrow cells in recipients of marrow depleted of lymphocytes using counterflow centrifugation
26. Mixed chimaerism; Detection and significance following BMT
27. Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analyzed with antibody-coated fluorescent microspheres
28. A fluorescent microsphere method for the investigation of erythrocyte chimaerism after allogeneic bone marrow transplantation using antigenic differences
29. Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation
30. A simple salting out procedure for extracting DNA from human nucleated cells
31. Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit
32. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats
33. Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation
34. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers
35. Analysis of T cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T cell-depleted and unmanipulated grafts
36. Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era
37. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
38. Characterization of lineage-specific chimerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse
39. Mixed chimerism: Preclinical studies and clinical applications
40. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: The impact of quantitative PCR analysis for prediction of relapse and graft rejection in children
41. Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation
42. Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
43. Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences
44. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia
45. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms
46. Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors
47. Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic bmt in children with acute leukemia: Is there an option to prevent relapse
48. Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T cell-depleted bone marrow transplantation and after donor leucocyte infusion
49. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation
50. Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: Mechanisms of escape from the 'graft versus leukemia′ effect
51. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
52. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
53. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation
54. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia
55. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse